H. Hayashi et al., Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia, ONCOL REP, 8(6), 2001, pp. 1275-1279
Several in vitro studies have shown that nitric oxide (NO) produced by NO s
ynthase (NOS), such as inducible NOS (iNOS) play an important role in tumor
biology. We immunohistochemically examined the expression of iNOS and p53
proteins in patients with transitional cell carcinoma (TCC) of the urinary
tract, including adjacent dysplastic lesions to determine the significance
of the tumor behavior. Of total 94 tumors, in the present study, 41 (43.6%)
tumors exhibited homogeneous immunostaining (diffuse strong positivity in
tumor cells, > 60%) and 53 (56.4%) tumors heterogeneous staining (variable
positivity in tumor cells, 20-60%). No TCCs exhibited negative iNOS immunos
taining, was found. Thirty (31.9%) of 94 TCCs were positive with anti-p53 a
ntibody, including 23 of homogeneous and 7 of heterogeneous staining. Of 23
TCCs with homogeneous p53 immunostaining, 11 tumors exhibited homogeneous
iNOS immunoreaction. In the present study, dysplastic lesions adjacent to c
arcinomas were detected in 64 cases including 36 TCCs with homogeneous iNOS
expression. All dysplastic lesions adjacent to the 36 TCCs with homogeneou
s iNOS immunostaining exhibited homogeneous iNOS immunostaining. No signifi
cant association between iNOS immunoreactivity and any clinicopathological
factors as well as p53 immuno-reactivity were found. These in vivo findings
provide evidence for frequent iNOS protein expression in TCC. In addition,
our observations indicate that overexpression of iNOS expression may be on
e of the early events in the carcinogenesis of TCC.